Literature DB >> 10591243

Managing dyslipidemia in older adults.

C M Carlsson1, M Carnes, P E McBride, J H Stein.   

Abstract

OBJECTIVES: To summarize and critically review clinical trial data regarding dyslipidemia as a risk factor for coronary heart disease (CHD) and the efficacy and safety of lipid-lowering interventions in older adults. Based on these data, clinical recommendations for diagnosing and managing dyslipidemia in older adults are provided.
METHODS: Peer-reviewed journal articles were identified by a MEDLINE search and a review of journal article references. Studies that were performed exclusively in subjects older than 65 years or that included a large subgroup of older adults were included.
CONCLUSIONS: Elevated low density lipoprotein and total cholesterol levels are independent risk factors for CHD events in patients aged older than 65 years. Older adults have a higher risk of mortality attributable to hypercholesterolemia. Diet and lipid-lowering medications safely and effectively lower cholesterol levels in this age group. Exercise increases high-density lipoprotein cholesterol levels and decreases triglyceride levels. If accompanied by weight loss, exercise may reduce low-density lipoprotein and total cholesterol levels. Improving lipid levels in older adults with CHD decreases the risk of future coronary events by up to 45%, and significant effects on outcome measures may be observed within 2 years of the initiation of therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10591243     DOI: 10.1111/j.1532-5415.1999.tb01568.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  3 in total

1.  Statins for stroke should be considered in biologically fit people over 75.

Authors:  J Kelly; A Rudd
Journal:  BMJ       Date:  2000-05-06

2.  Health-related quality of life and long-term therapy with pravastatin and tocopherol (vitamin E) in older adults.

Authors:  Cynthia M Carlsson; Kristi Papcke-Benson; Molly Carnes; Patrick E McBride; James H Stein
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

3.  Dyslipidemia.

Authors:  Adam M. Cohen; Daniel J. Rader
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.